Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bruce F. Farber is active.

Publication


Featured researches published by Bruce F. Farber.


Clinical Infectious Diseases | 2012

Using High-Technology to Enforce Low-Technology Safety Measures: The Use of Third-party Remote Video Auditing and Real-time Feedback in Healthcare

Donna Armellino; Erfan Hussain; Mary Ellen Schilling; William Senicola; Ann Eichorn; Yosef Dlugacz; Bruce F. Farber

BACKGROUND Hand hygiene is a key measure in preventing infections. We evaluated healthcare worker (HCW) hand hygiene with the use of remote video auditing with and without feedback. METHODS The study was conducted in an 17-bed intensive care unit from June 2008 through June 2010. We placed cameras with views of every sink and hand sanitizer dispenser to record hand hygiene of HCWs. Sensors in doorways identified when an individual(s) entered/exited. When video auditors observed a HCW performing hand hygiene upon entering/exiting, they assigned a pass; if not, a fail was assigned. Hand hygiene was measured during a 16-week period of remote video auditing without feedback and a 91-week period with feedback of data. Performance feedback was continuously displayed on electronic boards mounted within the hallways, and summary reports were delivered to supervisors by electronic mail. RESULTS During the 16-week prefeedback period, hand hygiene rates were less than 10% (3933/60 542) and in the 16-week postfeedback period it was 81.6% (59 627/73 080). The increase was maintained through 75 weeks at 87.9% (262 826/298 860). CONCLUSIONS The data suggest that remote video auditing combined with feedback produced a significant and sustained improvement in hand hygiene.


The American Journal of Medicine | 1993

Risk of human immunodeficiency virus infection among emergency department workers

Ruthanne Marcus; David H. Culver; David M. Bell; Pamela U. Srivastava; Meryl H. Mendelson; Robert J. Zalenski; Bruce F. Farber; Denise Fligner; Joseph Hassett; Thomas C. Quinn; Charles A. Schable; Edward P. Sloan; Paulus Tsui; Gabor D. Kelen

PURPOSE To estimate (1) the prevalence of human immunodeficiency virus (HIV) infection in emergency department (ED) patients, (2) the frequency of blood contact (BC) in ED workers (EDWs), (3) the efficacy of gloves in preventing BC, and (4) the risk of HIV infection in EDWs due to BC. PATIENTS AND METHODS We conducted an 8-month study in three pairs of inner-city and suburban hospital EDs in high AIDS incidence areas in the United States. At each hospital, blood specimens from approximately 3,400 ED patients were tested for HIV antibody. Observers monitored BC and glove use by EDWs. RESULTS HIV seroprevalence was 4.1 to 8.9 per 100 patient visits in the 3 inner-city EDs, 6.1 in 1 suburban ED, and 0.2 and 0.7 in the other 2 suburban EDs. The HIV infection status of 69% of the infected patients was unknown to ED staff. Seroprevalence rates were highest among patients aged 15 to 44 years, males, blacks and Hispanics, and patients with pneumonia. BC was observed in 379 (3.9%) of 9,793 procedures; 362 (95%) of the BCs were on skin, 11 (3%) were on mucous membranes, and 6 (2%) were percutaneous. Overall procedure-adjusted skin BC rates were 11.2 BCs per 100 procedures for ungloved workers and 1.3 for gloved EDWs (relative risk = 8.8; 95% confidence interval = 7.3 to 10.3). In the high HIV seroprevalence EDs studied, 1 in every 40 full-time ED physicians or nurses can expect an HIV-positive percutaneous BC annually; in the low HIV seroprevalence EDs studied, 1 in every 575. The annual occupational risk of HIV infection for an individual ED physician or nurse from performing procedures observed in this study is estimated as 0.008% to 0.026% (1 in 13,100 to 1 in 3,800) in a high HIV seroprevalence area and 0.0005% to 0.002% (1 in 187,000 to 1 in 55,000) in a low HIV seroprevalence area. CONCLUSIONS In both inner-city and suburban EDs, patient HIV seroprevalence varies with patient demographics and clinical presentation; the infection status of most HIV-positive patients is unknown to ED staff. The risk to an EDW of occupationally acquiring HIV infection varies by ED location and the nature and frequency of BC; this risk can be reduced by adherence to universal precautions.


Drugs | 1994

Multidrug-resistant Enterococcus faecium : an untreatable nosocomial pathogen

Richard V. Spera; Bruce F. Farber

SummaryThe prevalence of enterococci and nosocomial pathogens has increased over the past 15 years. They have become increasingly resistant to agents traditionally useful in the treatment of invasive diseases due to enterococci.Vancomycin resistance, first described in clinical isolates in 1988, has disseminated worldwide. It is usually associated with high-level resistance to penicillins and aminoglycosides rendering the treatment of patients with vancomycin-resistant enterococci very difficult. Several investigators have reported mortality rates greater than 50% for vancomycin-resistant enterococcal bacteraemia. Risk factors associated with vancomycin-resistant enterococcal bacteraemia include prolonged hospital stay, neutropenia, prior oral or parenteral vancomycin use, and broad spectrum antibiotics.Since there is no uniformly effective antimicrobial therapy for patients infected with vancomycin-resistant enterococci, preventing of the spread of infection with the rigorous application of barrier precautions and other infectious control techniques is of paramount importance.


Infection Control and Hospital Epidemiology | 1995

Skin and mucous membrane contacts with blood during surgical procedures: risk and prevention.

Jerome I. Tokars; David H. Culver; Meryl H. Mendelson; Edward P. Sloan; Bruce F. Farber; Denise Fligner; Mary E. Chamberland; Ruthanne Marcus; Penny S. McKibben; David M. Bell

OBJECTIVE To study the epidemiology and preventability of blood contact with skin and mucous membranes during surgical procedures. DESIGN Observers present at 1,382 surgical procedures recorded information about the procedure, the personnel present, and the contacts that occurred. SETTING Four US teaching hospitals during 1990. PARTICIPANTS Operating room personnel in five surgical specialties. MAIN OUTCOME MEASURES Numbers and circumstances of contact between the patients blood (or other infective fluids) and surgical personnels mucous membranes (mucous membrane contacts) or skin (skin contacts, excluding percutaneous injuries). RESULTS A total of 1,069 skin (including 620 hand, 258 body, and 172 face) and 32 mucous membrane (all affecting eyes) contacts were observed. Surgeons sustained most contacts (19% had > or = 1 skin contact and 0.5% had > or = 1 mucous membrane-eye contact). Hand contacts were 72% lower among surgeons who double gloved, and face contacts were prevented reliably by face shields. Mucous membrane-eye contacts were significantly less frequent in surgeons wearing eyeglasses and were absent in surgeons wearing goggles or face shields. Among surgeons, risk factors for skin contact depended on the area of contact: hand contacts were associated most closely with procedure duration (adjusted odds ratio [OR], 9.4; > or = 4 versus < 1 hour); body contacts (arms, legs, and torso) with estimated blood losses (adjusted OR, 8.4; > or = 1,000 versus < 100 mL); and face contacts, with orthopedic service (adjusted OR, 7.5 compared with general surgery). CONCLUSION Skin and mucous membrane contacts are preventable by appropriate barrier precautions, yet occur commonly during surgery. Surgeons who perform procedures similar to those included in this study should strongly consider double gloving, changing gloves routinely during surgery, or both.


The American Journal of Medicine | 1991

Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection

Mark H. Kaplan; William W. Hall; Myron Susin; Savita Pahwa; S.Zaki Salahuddin; Conrad Heilman; James Fetten; Maria Coronesi; Bruce F. Farber; Sharon M. Smith

Two intravenous drug users dually infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type II (HTLV-II) developed an unusual severe dermatitis characterized by progressive brawny induration, fissuring, and ulceration of the skin, with an associated CD8 cell infiltration in one patient. Both patients had persistent eosinophilia. Lymph node biopsy revealed dermatopathic lymphadenopathy, an unusual pathologic finding in HIV-1 infection but one seen in association with mycosis fungoides and other skin disorders. Two new isolates of HTLV-II virus were established from these patients and were identified as HTLV-II by Southern blotting. This type of skin disease and lymph node pathology has not been found in other intravenous drug users who have been infected with HIV-1 alone or in patients in other risk groups for HIV-1 infection. HTLV-II may play a role in this unique new disease pattern in patients infected with HIV-1.


Antimicrobial Agents and Chemotherapy | 1983

Multiply resistant viridans streptococci: susceptibility to beta-lactam antibiotics and comparison of penicillin-binding protein patterns.

Bruce F. Farber; George M. Eliopoulos; J I Ward; K L Ruoff; V Syriopoulou; Robert C. Moellering

A unique group of viridans streptococci has been found in South Africa. These organisms were isolated in close temporal and physical proximity to the isolation of penicillin-resistant pneumococci. The strains were resistant to penicillin, oxacillin, the cephalosporins (all generations), piperacillin, azlocillin, and mezlocillin but were susceptible to vancomycin. Penicillin-binding proteins of two penicillin-resistant South African strains of Streptococcus mitis differed markedly from those of two penicillin-susceptible strains but were identical to those seen in a penicillin-resistant strain isolated in Boston. Although both susceptible strains were identified as S. mitis with identical biochemical profiles, their penicillin-binding protein patterns differed from each other. This finding may have significance with regard to the need for additional taxonomic classification of the viridans streptococci. Images


Ophthalmology | 1995

A Novel Antibiofilm Technology for Contact Lens Solutions

Bruce F. Farber; Hsi-Chin Hsieh; Eric D. Donnenfeld; Henry D. Perry; Arthur B. Epstein; Arlene G. Wolff

PURPOSE Nonsteroidal anti-inflammatory drugs, including sodium salicylate, inhibit extracellular bacterial biofilm production. The authors studied the effect of the addition of sodium salicylate on bacterial adherence and biofilm formation on contact lenses and cases and commonly used medical polymers. METHODS The study was done in vitro with bacterial adherence and biofilm measured on lenses and cases that were exposed to saline contaminated with Staphylococcus epidermidis and Pseudomonas aeruginosa with and without 1 and 3 mm sodium salicylate. Bacterial adherence to contact lenses was quantitated by a vortex assay and by scanning electron microscopy. Biofilm formation on contact lens cases and other polymers was measured by an optical density assay and a radiolabeling assay. RESULTS Inhibition of biofilm formation was demonstrated on plastic contact lens cases in a dose-related manner with 1 and 3 mm sodium salicylate. A dose-related decrease in bacterial adherence also was noted. Assays with contact lenses also demonstrated less adherence in the presence of sodium salicylate. Electron micrographs of the contact lens showed less biofilm, most noticeable with 3 mm salicylate. Other studies demonstrated decreased adherence of S. epidermidis to polyethylene and polystyrene. Sodium salicylate also decreased biofilm on plastic tissue culture wells, but sorbic acid paradoxically increased deposition. CONCLUSION The authors found that the addition of low-dose sodium salicylate to saline decreased the adherence of S. epidermidis and P. aeruginosa to contact lenses and lens cases. Biofilm production also was decreased on the lens cases and on medical polymers used to make plastic cases. These studies suggest that sodium salicylate deserves additional study to determine its use in contact lens solutions.


Infection Control and Hospital Epidemiology | 1991

Clinical Significance of Neutropenia in Patients With Human Immunodeficiency Virus Infection

Bruce F. Farber; Martin Lesser; Mark H. Kaplan; Jeanine Woltmann; Barbara Napolitano; Donna Armellino

OBJECTIVE To determine the incidence of infection in human immunodeficiency virus (HIV)-infected patients during periods of neutropenia and non-neutropenia. To compare the infection rates in patients with HIV disease to those in a group hospitalized with neutropenia and hematologic malignancy. DESIGN Prospective observational study conducted between December 1985 and December 1987 at a university teaching hospital. Thirty patients with documented acquired immunodeficiency syndrome (AIDS) and absolute T-helper cells less than 200 mm/mm3. All patients had a period of non-neutropenia following a neutropenic period (neutrophils less than 1000 cells/mm3). RESULTS The rate of first infection during neutropenic and non-neutropenic periods for opportunistic infection and nonopportunistic infections were compared. There were no differences between infection rates for the two time periods for both types of infections. A subgroup of patient care days in which non-neutropenic days followed neutropenic days also was studied to eliminate selection bias. In this group, a comparison of infection rates also revealed no difference between neutropenic and non-neutropenic periods. An alternate analysis of the time until first infection during periods of neutropenia or non-neutropenia was done using the Kaplan-Meier product limit method. There was a longer infection-free period for the neutropenic group for opportunistic infections, but it was not statistically significant (p less than .1). In addition, we compared HIV-infected patients with a group of 37 patients with neutropenia from hematologic malignancy. There was a significantly higher rate of all infections, particularly bacteremias (p less than .001), in the group of patients with hematologic malignancies when compared with all subsets of patients with HIV disease. CONCLUSION We conclude that patients with HIV disease and modest neutropenia do not have an increased risk of bacterial infection. The incidence of all infections is significantly greater in patients with neutropenia secondary to hematologic malignancy.


American Journal of Infection Control | 2013

Replicating changes in hand hygiene in a surgical intensive care unit with remote video auditing and feedback

Donna Armellino; Manish Trivedi; Isabel Law; Narendra Singh; Mary Ellen Schilling; Erfan Hussain; Bruce F. Farber

Using remote video auditing (RVA) and real-time feedback, we replicated health care workers hand hygiene in a second intensive care unit. During the first 4 weeks using RVA without feedback, the compliance rate was 30.42%. The rate during the 64-week postfeedback period (initial 16 and 48 weeks maintenance) with RVA and feedback exceeded 80% on average. These data demonstrate that improved hand hygiene was achieved and sustained with the use of RVA and feedback.


The Journal of Urology | 1993

The Use of Salicylic Acid to Prevent the Adherence of Escherichia Coli to Silastic Catheters

Bruce F. Farber; Arlene G. Wolff

We studied the effect of salicylic acid on the attachment of Escherichia coli to silastic catheters. Silastic catheters were exposed to organisms grown in the presence of subinhibitory concentrations (1 and 5 mM.) of salicylic acid. An agar rolling technique demonstrated 59% and 79% inhibition of adherence with the 2 concentrations, respectively. Silastic catheters were also pretreated by heating and then incubating in 200 mM. and 600 mM. salicylic acid in 95% ethanol at -20C. After incubation in 10(4) CFU/ml. E. coli for 5 hours at 37C, 62% and 93% inhibition of adherence was observed. Acetylsalicylic acid and ibuprofen did not demonstrate similar results. Similar inhibition (82% and 95%) was observed despite preincubation of the treated catheters in sterile urine for 4 days. A bioluminescent assay of bacterial adherence also revealed inhibition only with salicylic acid. Studies using 3H-leucine demonstrated a decrease in adherence with higher concentrations of salicylic acid. Finally, tridodecylmethylammonium was used to bind salicylic acid to silastic catheters. After a 5-hour incubation in 10(4) CFU/ml. at 37C, 94% and 99% inhibition were observed with 200 and 600 mM. salicylic acid. Salicylic acid decreases adherence of E. coli to silastic catheters. This observation may be of value in designing catheters less likely to cause urinary tract infection.

Collaboration


Dive into the Bruce F. Farber's collaboration.

Top Co-Authors

Avatar

Arlene G. Wolff

North Shore University Hospital

View shared research outputs
Top Co-Authors

Avatar

Donna Armellino

North Shore-LIJ Health System

View shared research outputs
Top Co-Authors

Avatar

Adolf W. Karchmer

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

George M. Eliopoulos

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ann Eichorn

North Shore-LIJ Health System

View shared research outputs
Top Co-Authors

Avatar

David H. Culver

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

David M. Bell

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Edward P. Sloan

University of Illinois at Chicago

View shared research outputs
Researchain Logo
Decentralizing Knowledge